Latest information on COVID-19
Support teaching, research, and patient care.
Modern anti-cancer therapies have extended the survival times for many cancer patients but there is still improvements to be made as cancer mortality rates have, except for a few types of cancer, remained consistently high over the last five decades. By identifying highly sensitive imaging probes for the detection of cancer and its pre-steps we will improve outcomes for patients with the cancer through early detection, guided resection and thereby contribute to the reduction of the morbidity and mortality due to this malignant disease. In future those tools could work as well a therapeutics, which would open a new field - THERANOSTIC.
350 Campus Drive, Stanford, USA
Anti-angiogenic drugs opened a new field in anti-cancer therapy. There mechanism is unique and in contrast to classic chemotherapeutic drugs well-tolerated. The well known anti-septic drug Taurolidine as well Emodin were tested on several completely different cancer entities such as colon cancer, melanoma and osteosarcoma in vitro and in vivo.
Augustenburger Platz 1, Berlin, Germany
318 Campus Drive, Stanford, Ca 94305
Development of new predictive biomarkers for IBD using multiparametric studies.
European Society for Molecular Imaging (ESMI)
Scientists in the Field of Imaging
The research interest of myself and my lab are in the field of early cancer detection using targeted molecular spies to highlight (pre)cancerous lesions. We as well aim to improve precision medicine in autoimmune disorders like inflammatory bowel disease and oncology.